Thrivent Financial for Lutherans’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-63,960
| Closed | -$273K | – | 2439 |
|
|
2023
Q2 | $273K | Sell |
63,960
-10
| -0% | -$43 | ﹤0.01% | 2347 |
|
|
2023
Q1 | $438K | Sell |
63,970
-2,248
| -3% | -$15.4K | ﹤0.01% | 2179 |
|
|
2022
Q4 | $524K | Sell |
66,218
-469
| -0.7% | -$3.71K | ﹤0.01% | 2095 |
|
|
2022
Q3 | $641K | Buy |
66,687
+3,553
| +6% | +$34.2K | ﹤0.01% | 1947 |
|
|
2022
Q2 | $457K | Buy |
63,134
+11,252
| +22% | +$81.4K | ﹤0.01% | 2130 |
|
|
2022
Q1 | $670K | Buy |
51,882
+17
| +0% | +$220 | ﹤0.01% | 2050 |
|
|
2021
Q4 | $828K | Buy |
51,865
+555
| +1% | +$8.86K | ﹤0.01% | 1966 |
|
|
2021
Q3 | $825K | Sell |
51,310
-3,186
| -6% | -$51.2K | ﹤0.01% | 1947 |
|
|
2021
Q2 | $754K | Buy |
54,496
+1,874
| +4% | +$25.9K | ﹤0.01% | 2002 |
|
|
2021
Q1 | $769K | Buy |
52,622
+142
| +0.3% | +$2.08K | ﹤0.01% | 2024 |
|
|
2020
Q4 | $912K | Buy |
52,480
+330
| +0.6% | +$5.74K | ﹤0.01% | 1813 |
|
|
2020
Q3 | $956K | Buy |
52,150
+1,104
| +2% | +$20.2K | ﹤0.01% | 1581 |
|
|
2020
Q2 | $912K | Buy |
+51,046
| New | +$912K | ﹤0.01% | 1562 |
|
|
2018
Q3 | – | Sell |
-58,137
| Closed | -$814K | – | 2011 |
|
|
2018
Q2 | $814K | Buy |
58,137
+314
| +0.5% | +$4.4K | ﹤0.01% | 1392 |
|
|
2018
Q1 | $639K | Buy |
57,823
+683
| +1% | +$7.55K | ﹤0.01% | 1498 |
|
|
2017
Q4 | $503K | Hold |
57,140
| – | – | ﹤0.01% | 1685 |
|
|
2017
Q3 | $762K | Hold |
57,140
| – | – | ﹤0.01% | 1325 |
|
|
2017
Q2 | $820K | Hold |
57,140
| – | – | ﹤0.01% | 1229 |
|
|
2017
Q1 | $1.21M | Hold |
57,140
| – | – | 0.01% | 1069 |
|
|
2016
Q4 | $1.61M | Buy |
+57,140
| New | +$1.61M | 0.01% | 945 |
|